NAG-1 and EGCG has demonstrated encouraging preclinical results against panel of HNSCC, oral cavity SCC, larynx SCC.
The mechanism of EGCG mediated antitumor activity is currently under study. Observed effects include inhibition of MTT assay, Transfection and induction of tumor cell apoptosis.
In this study, we investigated the effect of EGCG-induced NAG-1 induction of apoptosis in HNSCC cancer lines. Subsequently, we found that pro-apoptotic proteins (NAG-1 and p53) and cell cycle inhibitor (p21) were induced in the presence of EGCG, and kinase pathways, including ataxia telangiectasia mutated (ATM), play an important role in activating these.
Given the critical role for ATM in the cellular response to the prominent, although not
exclusive, role for ATM in the phosphorylation of p53 in response to NAG-1 expression,
we sought to examine the effects of EGCG, on ATM and its downstream effectors.
EGCG-induced NAG-1 as a chemopreventative or therapeutic agent in HNSCC.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Total Visit :2,787,253
Total Download :1,136,409
Today View :892
Ajou University Medical Information & Media Center 164 Worldcup-ro Yeongtong-gu Suwon 16499 Korea / TEL : 031-219-5312 / FAX : 031-219-5314 Copyright (c) Ajou University Medical Information & Media Center All Rights Reserved. AJOU Open Repository는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.